Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding percutaneous coronary intervention (PCI), according to late breaking research presented in a Hot Line session at ESC Congress 2023

News | Optical Coherence Tomography (OCT)

Optical Coherence Tomography Non-inferior to Intravascular Ultrasound for Stent Guidance

August 29, 2023 — Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding ...

August 29, 2023

The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online today in European Heart Journal.

News | Heart Failure

First ESC Guidelines Covering All Acute Coronary Syndromes Published

August 29, 2023 — The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online ...

August 29, 2023

Data from the landmark ILUMIEN IV trial, the first randomized imaging trial with global representation, has the potential to change clinical practice related to stent placement

News | Optical Coherence Tomography (OCT)

Abbott Unveils Late-breaking Data Showing Intravascular Imaging Via OCT can Improve Stent Procedural Outcomes, Especially in Complex Cases

August 29, 2023 — Abbott announced late-breaking data from the first-of-its-kind ILUMIEN IV OPTIMAL PCI (ILUMIEN IV) ...

August 29, 2023

The PROFID EHRA trial is set to answer this question in a large, multicentre, EU-funded study set to enrol the first patient this summer.

News | Implantable Cardioverter Defibrillator (ICD)

Trial Re-evaluates Routine Defibrillator Implantation After Myocardial Infarction

August 28, 2023 — Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial ...

August 28, 2023

HEART-FID trial presented in a Hot Line session Saturday at ESC Congress 2023

News | Heart Failure

Trial of Ferric Carboxymaltose in Heart Failure Does Not Meet Primary Endpoint

August 28, 2023 — Ferric carboxymaltose(FCM) did not improve a hierarchical outcome of death, heart failure hospitalizat ...

August 28, 2023

BUDAPEST CRT Upgrade trial presented in a Hot Line Session Saturday at ESC Congress 2023

News | Implantable Cardioverter Defibrillator (ICD)

Upgrade to Cardiac Resynchronization Therapy Benefits Heart Failure Patients with Pacing

August 28, 2023 — Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and ...

August 28, 2023

STOPDAPT-3 trial presented in a Hot Line Session Saturday at ESC Congress 2023

News | Antiplatelet and Anticoagulation Therapies

Dual-antiplatelet Therapy Should Remain Standard Strategy After Stent Implantation

August 28, 2023 — Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not ...

August 28, 2023

Videos | Pharmaceuticals

VIDEO, Part 1: Hypertrophic Cardiomyopathy: One on One with a Cardiovascular Research Leader

A 3-part video series with Christine E. Seidman, MD, FACC, FAHA

In the first of this 3-part “One on One” series, Dr ...

August 28, 2023

Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced that its MyoVista wavECG has been selected by PanaceaFlo Ltd to be used in Dublin, Ireland in its heart screening evaluation study

News | Artificial Intelligence

HeartSciences’ MyoVista wavECG Selected to be used in Irish Heart Screening Evaluation

August 24, 2023 —Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical ...

August 24, 2023

Giant in the field of cardiac electrophysiology remembered by colleagues and friends at UH Harrington Heart & Vascular Institute

Feature | Cardiovascular Business

Albert L. Waldo, MD, Has Passed Away After Brief Illness

August 22, 2023 — Leaders at University Hospitals (UH) Harrington Heart & Vascular Institute are saddened to share news ...

August 22, 2023

AI enhancing Cedars-Sinai patient care, clinical and research initiatives, and medical discoveries

News | Artificial Intelligence

Cedars-Sinai Charts Healthcare’s Future With Artificial Intelligence

August 17, 2023 — Artificial intelligence (AI) is capturing the public imagination as the pace of innovation accelerates ...

August 18, 2023

News | AHA

Study Links Pain After Heart Attack to Mortality Predictability

August 16, 2023 —Moderate or extreme pain after a heart attack – most commonly pain due to other health conditions – may ...

August 16, 2023

Clario and AliveCor provide a new trial participant-friendly solution for cutting-edge, at-home data collection with privacy protection, instrumental in situations where traditional 12-lead ECG cannot be collected.

News | ECG

Clario and AliveCor Collaborate to Offer Advanced, Trial- focused Six-lead ECG Solutions for Monitoring in Decentralized Clinical Trials

August 15, 2023 — Clario, a healthcare research technology company that delivers leading endpoint technology solutions ...

August 15, 2023

E-cigarettes likely not healthier alternative to traditional cigarettes

News | Stroke

New Evidence Bolsters Theory E-cigarettes May Increase Stroke Risk

August 15, 2023 — There is new evidence that bolsters a possible link between e-cigarette use and increased risk of ...

August 15, 2023

Esperion announced two oral presentations to take place in the Late-Breaking Science Session entitled “Clinical trial updates on prevention and lipid lowering” at the 2023 ESC Congress

News | Cardiovascular Clinical Studies

Two CLEAR Outcomes Study Late-Breakers Accepted at European Society of Cardiology (ESC) Congress 2023

August 14, 2023 — Esperion announced two oral presentations to take place in the Late-Breaking Science Session entitled ...

August 14, 2023